Clinical Trial Update: Adipose Derived Regenerative Cells In the Treatment of Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for adipose-derived regenerative cells in treating diabetic foot ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Adipose-derived Regenerative Cells (Adipose-derived Regenerative Cells)

Snippet

Sponsor: Paracrine, INC. | Conditions: Diabetic Foot Ulcer | Phase 3 | Status: UNKNOWN